75 articles
Philip Kantoff, Co-founder and CEO of Convergent Therapeutics, a clinical-stage pharmaceutical company focused on developing next-generation radiopharma...
Rakesh Jain, Clinical Professor, Department of Psychiatry, Texas Tech School of Medicine, Austin, TX discusses tardive dyskinesia or TD, a chronic condi...
Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen's Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma.
In this segment, Neal speaks with healthcare veteran Nancy Lurker, President and CEO of EyePoint Pharmaceuticals, who discussed how Lurker transformed E...
Janssen Immunology has a track record of defining and redefining the treatment of immune-mediated disease. Learn more on Health Professional Radio.
Angela Stoehr, OB/GYN, addresses how the pandemic exacerbated the opioid epidemic and the need to refocus on non-opioid pain management approaches after...
Hematology and Oncology at Jazz Pharmaceuticals, discusses the "Nothing Small About It" online program developed with leading cancer organizations focus...
Chris Anzalone, PhD, President and CEO of Arrowhead Pharmaceuticals discusses new positive patient-level data from their AROAAT2002 global Phase 2 study...
James Tursi, MD, Chief Scientific Officer of Ferring Pharmaceuticals discusses developments in microbiome-based therapeutics for the treatment of recurr...
Jennifer Gudeman, Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals discusses new clinical data from the pivotal phase 3 REST-ON cl...